Mike Boesveld, Director, Marketplace Strategy, PointClickCare. "We are excited to integrate with AccessDx Laboratory to jointly help our mutual clients manage the complex challenges of long-term and post-acute care." About AccessDx Laboratory:...
a strategic collaboration with DP Technology for AI-assisted drug R&D, aiming to integrate AI with physical modeling to jointly advance new drug development processes. This collaboration leverages DP Technology's technical strength and project...
portfolio of pharmaceutical development and manufacturing services to Jabil’s current healthcare solutions. By joining Jabil, Pii gains access to an expanded global infrastructure, cutting-edge automation, and enhanced supply chain efficiencies,...
welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare, and Global Brain in this financing. Zafrens' breakthrough platform...
to double digits on net sales. About HBM9378/SKB378: HBM9378/SKB378 (also known as WIN378) is a co-development project jointly conducted by Harbour BioMed and Kelun-Biotech, with both parties equally sharing its rights in Greater China and several...
and executing capital raises to support Avanzanite’s rapid growth and strategic partnerships. “It is a great privilege to join Avanzanite and support its mission to address unmet needs of rare disease patients,” said Mr. Omari. “With its highly...
growth, and perspective as a current public company CEO make him a perfect fit for our Board. "I am excited to be joining Azenta at a critical time in their evolution," said Dipal Doshi. "Azenta's strong market leadership position and its...
such as life sciences, healthcare, industrial manufacturing, aerospace, and semiconductor production. Jason Thompson joins the Modular Devices team as Director of Cleanroom Sales, bringing more than 20 years of leadership experience in sales,...
across multiple target classes covering oncology, immunology, neurology, ophthalmology and metabolic disease. He joins from Storm Therapeutics — where he was Senior Vice President of Therapeutics — and has held Senior Leadership positions at...
robotics and AI at scale to digitally design, discover and make new molecules, announced that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global...
therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience,...
step forward in our mission to transform lupus nephritis treatment," said Dr. Alon Yaar, CEO of LIVEKIDNEY.BIO. "By joining forces with Isotopia, we are confident we can provide a much-needed, high-quality solution to improve the lives of millions...
here. The participant toll-free dial-in number is 1-800-836-8184 for North America and Canada. It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A live webcast of the call will be available under...
trends and client needs, earning her recognition as a trusted advisor to both clients and colleagues. In 2024, Nicole joined Petauri to develop and lead the organization's US HEOR consultancy team. In this role, she is building the evidence team...
applications for market approval and commercialization of Lecanemab for Alzheimer's disease. BioArctic has the right to jointly commercialize Leqembi in the Nordic region, pending European approval, and currently Eisai and BioArctic are preparing...
Scinai Immunotherapeutics Ltd. a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced that Dr. Jonathan Sadeh has...
for the treatment of Duchenne muscular dystrophy (Duchenne), a rare muscle-wasting neurological disorder. Prior to joining NS Pharma, Foy served in leadership roles for 17 years in the pharmaceutical industry, with more than 24 years of experience...
insurances, Neoplas Med submitted an application for the trial study back in April 2021, which was approved by the Federal Joint Committee (G-BA) in February 2023. The National Association of Statutory Health Insurance Physicians recently published...
The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical, was recently presented at a major global academic conference, drawing significant...
started aRBCX in the U.S. more than 20 years ago, "There wasn't anything that was working for me. I would have pain in my joints, fatigue and jaundice." By receiving regular aRBCX procedures, she says "I don't have to worry about pain crises. I'm...
